ResultsIQ

ResultsIQ › Latest results › Jeena Sikho Lifecare Limited

Jeena Sikho Lifecare Limited Q4 FY26 results deck summary

NSE: JSLL · BSE: 544476

Results deck of 1 Jun 2026, summarised by AI from the filing.

Q4 FY26 revenue ₹21,555 lakh, up 55% YoY; FY26 EBITDA margin 44% vs 30% in FY25.

Key takeaways

  1. Q4 FY26 revenue Revenue from operations ₹21,555 lakh, up 55% YoY from ₹13,925 lakh.
  2. FY26 EBITDA margin FY26 EBITDA margin 44%, up from 30% in FY25.

Original filing on BSE

Jeena Sikho Lifecare Limited Q1 FY27 results

As filed: Revenue ₹224 cr (+29% year on year), EBITDA ₹92.1 cr (+15% year on year), PAT ₹65.9 cr (+29% year on year), EBITDA margin 41.0% (−495 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹216 cr (−15% year on year), EBITDA ₹78.0 cr (+18% year on year), PAT ₹45.4 cr (+3% year on year), EBITDA margin 36.2% (+1,000 bps). Score 41 of 100, In line with trend. EBITDA margin rose 1000 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 32% from last quarter. Share price after the results: −4.6% in 30 days (Nifty 500: +1.5%).
  • Q3 FY26: Revenue ₹222 cr, EBITDA ₹101 cr, PAT ₹66.7 cr, EBITDA margin 45.5%. Not scored. No result for the same quarter last year. Share price after the results: −14.4% in 30 days (Nifty 500: −5.9%).
  • Q2 FY26: Revenue ₹190 cr (−11% year on year), EBITDA ₹92.1 cr (+56% year on year), PAT ₹58.8 cr (+25% year on year), EBITDA margin 48.5% (+1,000 bps). Score 60 of 100, In line with trend. EBITDA margin rose 1000 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −12.8% in 29 days (Nifty 500: +1.4%).
  • Q1 FY26: Revenue ₹174 cr, EBITDA ₹80.0 cr, PAT ₹51.0 cr, EBITDA margin 46.0%. Not scored. No result for the same quarter last year. Share price after the results: +40.7% in 29 days (Nifty 500: +2.2%).
  • Q4 FY25: Revenue ₹255 cr, EBITDA ₹66.0 cr, PAT ₹44.0 cr, EBITDA margin 25.9%. Not scored. No result for the same quarter last year.
  • Q2 FY25: Revenue ₹214 cr (+173% year on year), EBITDA ₹59.0 cr (+162% year on year), PAT ₹47.0 cr (+194% year on year), EBITDA margin 27.6% (−109 bps). Score 89 of 100, Above trend. EBITDA margin fell 109 bps year on year. Year-ago figures are half of the company's half-year result (it reported half-yearly then). Not enough history for a trend yet: scored on growth alone.
  • H1 FY24: Revenue ₹157 cr, EBITDA ₹45.0 cr, PAT ₹32.0 cr, EBITDA margin 28.7%. Not scored. No result for the same half-year last year.

Past price moves after results do not indicate future moves. Not a recommendation.

Jeena Sikho Lifecare Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.